The high-grade glioma market is witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing awareness, and advancements ...

COPENHAGEN, DK / ACCESS Newswire / June 29, 2026 / FluoGuide A/S ("FluoGuide" or the "Company") (STO:FLUO), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today anno ...

COPENHAGEN, DK / ACCESS Newswire / June 29, 2026 / FluoGuide A/S ("FluoGuide" or the "Company") (STO:FLUO), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, ...

Patients with newly diagnosed glioblastoma received individualized total doses of ITM-31 in three fractions with an interval of 4 weeks between injections after completion of standard of care therapy.

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

The need for new treatments is particularly urgent. Glioblastoma remains among the most lethal cancers, with most patients ...

Deion “Coach Prime” Sanders says he feels like his old — and younger — self again a year after undergoing surgery to remove ...

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...

NewYork-Presbyterian's GLICO seeks to overcome glioblastoma's resistance by mimicking brain environments to test treatments ...

Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are ...